Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Advances in next-generation sequencing technologies have facilitated extensive analysis of B cell and T cell receptor (BCR/TCR, respectively) sequences from monoclonal hybridoma libraries, single B cells, and single T cells, generating vast amounts of important data pertaining to antigen recognition. However, existing workflows and bioinformatics tools often lack the flexibility and scalability needed to handle large clonal level datasets effectively. An initial system and hybridoma dependent version of this code was distributed as part of the NeuroMabSeq publication, but clonevdjseq aims to be a technical addendum for broader system compatibility and enhanced modeling.

Results: We present clonevdjseq, an integrated and accessible software solution leveraging nextflow and Django. Developed primarily for large hybridoma libraries, the workflow and pipeline is amenable to BCR/TCR sequence analysis of homogenous populations or clones of B and T cells, respectively. The clonevdjseq pipeline includes modules for read processing, amplicon denoising, and quality control of paired variable light/heavy chains of BCRs from B cells and hybridomas, or alpha(ɑ)/beta(β) and delta(δ)/gamma(γ) chains of TCRs in the case of T cell applications. The pipeline is built upon a robust, high-throughput library prep protocol, upon which processed data has been verified across thousands of monoclonal antibodies. The results of this effort has yielded sequences used to develop functional recombinant monoclonal antibodies and single chain variable fragments as a part of the NeuroMabSeq initiative where thousands of hybridoma samples were processed (Mitchell et al. in Sci Rep 13(1):16200, 2023) as well as provide additional modeling and extensibility to other modalities. The clonevdjseq software is accessible via Nextflow and also offers a database and web app as a final optional step in the processing for dissemination of results and data exploration.

Conclusions: clonevdjseq offers a comprehensive and scalable solution for the processing and analysis of large monoclonal and oligoclonal VDJ datasets. Its modular design, dynamic pipeline, and robust database integration facilitate efficient data management and analysis. The platform is publicly available and aims to support the research community by providing an accessible and flexible tool for archiving and dissemination of BCR sequences from hybridomas, with applicability for other applications such as TCR sequences from single-cell T cell populations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12278597PMC
http://dx.doi.org/10.1186/s12859-025-06107-2DOI Listing

Publication Analysis

Top Keywords

hybridoma libraries
8
single cells
8
monoclonal antibodies
8
clonevdjseq
6
analysis
5
sequences
5
clonevdjseq workflow
4
workflow bioinformatics
4
bioinformatics management
4
management system
4

Similar Publications

Background: Advances in next-generation sequencing technologies have facilitated extensive analysis of B cell and T cell receptor (BCR/TCR, respectively) sequences from monoclonal hybridoma libraries, single B cells, and single T cells, generating vast amounts of important data pertaining to antigen recognition. However, existing workflows and bioinformatics tools often lack the flexibility and scalability needed to handle large clonal level datasets effectively. An initial system and hybridoma dependent version of this code was distributed as part of the NeuroMabSeq publication, but clonevdjseq aims to be a technical addendum for broader system compatibility and enhanced modeling.

View Article and Find Full Text PDF

Monoclonal antibodies (mAbs) are a growing class of therapeutics known for their high specificity and diverse functional mechanisms, including agonism and antagonism. Although microwell array technologies and droplet microfluidics are employed to pair antibody-secreting cells (ASCs) with target cells for therapeutic mAb discovery, existing methods suffer from limited throughput or inadequate functional assessment. To address these limitations, we applied PicoShells, hollow media-permeable hydrogel microparticles, to evaluate mAb function by co-culturing hybridomas with reporter cells for 24 hours.

View Article and Find Full Text PDF

Protein tyrosine kinase 7 (PTK7), a receptor found in tumor-initiating cells, is expressed in various malignancies, including ovarian cancer. Whereas PTK7 has been explored as a target for antibody-drug conjugates, this study is the first to investigate its potential for targeted radionuclide therapy. We developed a murine monoclonal IgG1 antibody (mOI-1) using hybridoma technology and generated a chimeric version (chOI-1) with human IgG1 constant regions.

View Article and Find Full Text PDF

High-throughput strategies for monoclonal antibody screening: advances and challenges.

J Biol Eng

May 2025

Dongguan Key Laboratory of Pathogenesis and Experimental Diagnosis of Infectious Diseases, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, China.

Antibodies characterized by high affinity and specificity, developed through high-throughput screening and rapid preparation, are crucial to contemporary biomedical industry. Traditional antibody preparation via the hybridoma strategy faces challenges like low efficiency, long manufacturing cycles, batch variability and labor intensity. Advances in molecular biology and gene editing technologies offer revolutionary improvements in antibody production.

View Article and Find Full Text PDF

Antigen-specific recognition of microbiota by T cells enforces tolerance at homeostasis. Conversely, dysbiosis leads to imbalanced T-cell responses, triggering inflammatory and autoimmune diseases. Despite their significance, the identities of immunogenic microbial antigens remain largely enigmatic.

View Article and Find Full Text PDF